Life Scientist > Biotechnology

Liquid fat treatment provides hope for rare childhood disease

22 August, 2025

A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in patients with the degenerative disease known as Ataxia–telangiectasia.


NSW Govt delivers foot-and-mouth vaccine to protect livestock

20 August, 2025

A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as part of a research partnership between Meat & Livestock Australia, Tiba Biotech and the NSW Government.


Scientists optimise delivery of mRNA to target cells

19 August, 2025

A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded lipid nanoparticles while the antibodies are in their optimal orientation, thus enhancing the mRNA’s effectiveness.


HIV drugs suppress transmission of a different viral infection

05 August, 2025

The work could lead to the first treatments to prevent the spread of the life-threatening HTLV-1 virus, which is endemic among many First Nations communities around the world.


Oral drug shows promise for treating Barth syndrome

24 July, 2025

An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare genetic disorder affecting one in 300,000 births worldwide.


Novel drug candidates found for nerve pain and ischemic disease

09 July, 2025

The discovery paves the way for potential new treatments for health conditions linked to tissue stress and inflammation, without accompanying side effects.


Biomaterial helps to reverse aging in the heart

24 June, 2025

The discovery could open the door to therapies that rejuvenate the heart by changing its cellular environment, rather than the heart cells themselves.


Anti-inflammatory agent could decrease septic shock mortality

20 June, 2025

Researchers have discovered a naturally occurring blood protein — a type of corticosteroid-binding globulin (CBG) — that could significantly decrease mortality caused by septic shock.


mRNA used to force HIV out of hiding

17 June, 2025

Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to deliver mRNA to the elusive HIV reservoir and coax HIV out of hiding.


TGA approves therapy for paediatric growth hormone deficiency

11 June, 2025

The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged from 3–18 years due to insufficient endogenous growth hormone secretion.


WMFTS WMArchitect Interchangeable Parts service for single-use assemblies

10 June, 2025

Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.


Contact lens breakthrough lets humans see infrared light

29 May, 2025

Newly created contact lenses enable infrared vision in both humans and mice by converting infrared light into visible light — which could transform medical imaging and visual assistance technologies.


TGA approves donanemab for treatment of early Alzheimer's

23 May, 2025

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in Australia, while Spanish researchers have presented a new family of candidate compounds for the treatment of Alzheimer's and pain.


Diabetes drug reduces knee arthritis pain in overweight patients

16 May, 2025

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements.


Anti-inflammatory drug may help treat alcohol use disorder

09 May, 2025

A drug that is already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity — two issues that commonly co-occur with alcohol use disorder.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd